Article | May 4, 2022

Embracing LC-MS Analytical Techniques Into Regulated Laboratories

Source: Waters Corporation

By Heather Longden

Waters BioAccord article

Biopharmaceutical regulations and regulatory guidance help to ensure high performance across the industry, enabling laboratories to create better and more consistent drug therapies. Though the rules around compliance can be complex, they provide the structure for the pharmaceutical industry to succeed in releasing a safe and effective product.

To ensure compliance success in a changing regulatory landscape, laboratories must continually adapt in order to maintain compliance. Biopharma is presented with an additional compliance challenge, as the field requires complex analytical instruments that are not traditionally used in highly regulated labs.

One solution is the utilization of compliant-ready liquid chromatography-mass spectrometry (LC-MS), which can provide mass spectrometry detection for quality control analysis in Biopharma. As a fit-for-purpose, compliant-ready LC-MS system, Waters’ new BioAccord LC-MS platform addresses the biopharma compliance challenge by helping laboratories replace their less sensitive optical-based assays with a more advanced methodology.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online